Ekso Bionics Holdings (EKSO) EBIAT (2016 - 2025)
Historic EBIAT for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.
- Ekso Bionics Holdings' EBIAT rose 3141.89% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.4 million, marking a year-over-year increase of 626.18%. This contributed to the annual value of -$11.3 million for FY2024, which is 2545.07% up from last year.
- Ekso Bionics Holdings' EBIAT amounted to -$1.4 million in Q3 2025, which was up 3141.89% from -$2.7 million recorded in Q2 2025.
- In the past 5 years, Ekso Bionics Holdings' EBIAT ranged from a high of -$1.3 million in Q2 2021 and a low of -$4.6 million during Q1 2022
- Over the past 5 years, Ekso Bionics Holdings' median EBIAT value was -$3.2 million (recorded in 2022), while the average stood at -$3.1 million.
- Over the last 5 years, Ekso Bionics Holdings' EBIAT had its largest YoY gain of 8918.16% in 2021, and its largest YoY loss of 17985.32% in 2021.
- Over the past 5 years, Ekso Bionics Holdings' EBIAT (Quarter) stood at -$2.9 million in 2021, then dropped by 11.0% to -$3.2 million in 2022, then fell by 1.13% to -$3.2 million in 2023, then dropped by 6.19% to -$3.4 million in 2024, then skyrocketed by 58.37% to -$1.4 million in 2025.
- Its EBIAT was -$1.4 million in Q3 2025, compared to -$2.7 million in Q2 2025 and -$2.9 million in Q1 2025.